Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
Liang Shan(Washington University in St. Louis), Robert F. Siliciano(Johns Hopkins University), Christine M. Durand(Johns Hopkins University), Sifei Xing(Johns Hopkins University), Janet D. Siliciano(National Institutes of Health), S. Alireza Rabi(Johns Hopkins University), Ruian Ke(North Carolina State University), Nina N. Hosmane(Johns Hopkins University), Weiping Cai(Guangzhou Eighth People's Hospital), Kai Deng(Sun Yat-sen University), Adam A. Capoferri(Howard Hughes Medical Institute), Richard A. Flavell(Howard Hughes Medical Institute), Gregory M. Laird(Duke Medical Center), Hao Zhang(Johns Hopkins University), Joseph B. Margolick(Johns Hopkins University), Michelle Kim(Johns Hopkins University), Linghua Li(Guangzhou Eighth People's Hospital), Hongbo Gao(Sun Yat-sen University), Hung‐Chih Yang(Johns Hopkins University)
Cited by 184
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia.
|The Journal of Cell Biology|1986|1.6k
Lipidomics reveals a remarkable diversity of lipids in human plasma
|Journal of Lipid Research|2010|1.3k
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
|Journal of Infection|2020|1.2k